The skin's immune system consists of beneficial bacteria that act as its first line of environmental defense. When this microbiome ecosystem is off balance, our skin becomes more susceptible to invading pathogens and premature aging. When Probiotic Derived Bioactives are applied to the skin, they alter the skin's ratio of good-to-bad microorganisms, increase skin barrier integrity, optimize collagen and elastin levels, and decrease negative responses in the skin, drastically improving the health and appearance of all skin types.

While vitamin A (retinoids) is crucial for skin health, common forms can cause irritation, redness, and sun sensitivity. Patented and exclusive to GLOWBIOTICS, glyceryl diretinoate (GDR) solves these problems. By attaching retinoic acid to a triglyceride, we stabilize the retinoid, reduce its irritation profile, and allow it to be absorbed and released at the target site. This provides all the benefits of a high-performance retinoid with none of the irritation.

Peptides are the building blocks of proteins and work at the cellular level to increase cell-to-cell communication. GLOWBIOTICS utilizes a variety of lipo-oligopeptides—peptides with fatty acids attached for better delivery—designed for specific functions. They work like a lock and key with your skin's cells, signaling them to cause a change in genetic expression, which releases messenger molecules to neighboring cells to begin skin communication.

GLOWBIOTICS is one of the first medical skincare companies to pioneer the use of DNA microarray assay technology to take clinical validation to the next level. We apply an active ingredient or final formulation to a 3D cultured skin model. We then extract RNA from the cells and place it on a microarray panel, which allows us to see if the desired genetic markers are turned on (up-regulated) or turned off (down-regulated), proving the formula works on a cellular level.